Gut flora in multiple sclerosis: implications for pathogenesis and treatment

Area of Science:

• Neuroimmunology
• Microbiome Research
• Central Nervous System Disorders

Background:

• Multiple sclerosis (MS) is a chronic inflammatory, demyelinating, and neurodegenerative disease of the central nervous system (CNS).
• Current MS therapies manage symptoms and slow progression but do not offer a cure.
• The gut-brain axis describes bidirectional communication between the gut microbiota and the CNS, influencing immune and neurological functions.

Purpose of the Study:

• To review the current understanding of the gut flora's role in the pathogenesis of multiple sclerosis.
• To explore the implications of gut-brain axis dysregulation in MS.
• To identify potential therapeutic targets within the gut microbiome for MS management.

Main Methods:

• Literature review of studies investigating the gut microbiome in multiple sclerosis.
• Analysis of research on gut dysbiosis, systemic inflammation, and immune system modulation.
• Synthesis of findings on the gut-brain axis and its relevance to MS pathogenesis.

Main Results:

• Gut dysbiosis is associated with systemic inflammation and altered immune responses relevant to MS.
• The gut microbiome composition may influence the development and progression of multiple sclerosis.
• The gut-brain axis represents a significant pathway through which microbial imbalances can impact CNS health.

Conclusions:

• The gut flora plays a critical role in regulating immune responses implicated in multiple sclerosis.
• Understanding the gut-brain axis is crucial for developing novel and effective MS therapies.
• Targeting the gut microbiome offers a promising avenue for future multiple sclerosis treatment strategies.